Thomas Brinkman

Thomas Brinkman, MS, currently serves as the Director of Regulatory Clinical Science at ImmunityBio, Inc., a position held since September 2024. Prior to this role, Thomas worked at Hurley Consulting Associates Ltd. as a Senior Clinical Scientist, transitioning from a Clinical Scientist role from July 2021 to September 2024. Thomas's career also includes experience at Memorial Sloan Kettering Cancer Center, where Thomas advanced from Research Study Assistant to Clinical Research Supervisor between November 2016 and July 2021. Thomas holds a Master of Science in Clinical Research from New York University and a Bachelor of Science in Biotechnology from Rutgers University. In addition to academic achievements, Thomas has a solid foundation in microbiology techniques and laboratory skills, including experiment design and molecular biology applications.